Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.42 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.42 |
| ▸ | NAAA | Q02083 | 2/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.39 |
| ▸ | PPARG | P37231 | 7/20 | 0.39 |
| ▸ | PPARD | Q03181 | 7/20 | 0.39 |
| ▸ | PPARA | Q07869 | 7/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TLR2 | O60603 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6516407 | 1.00 | L3MBTL1 (0.47) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL6717843 | 0.84 | L3MBTL1 (0.44) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL9632473 | 0.82 | L3MBTL1 (0.42) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL28142318 | 0.81 | L3MBTL1 (0.46) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL28384679 | 0.81 | L3MBTL1 (0.46) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL2544911 | 0.80 | OPRM1 (0.34) | ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29663241 | 0.78 | L3MBTL1 (0.50) | L3MBTL1TDP1MEN1KMT2AGNAI3 | |
| SCHEMBL454182 | 0.75 | S1PR1 (0.41) | L3MBTL1TDP1MEN1KMT2A | |
| SCHEMBL28772993 | 0.75 | S1PR1 (0.41) | L3MBTL1TDP1MEN1KMT2A | |
| SCHEMBL10527688 | 0.75 | S1PR1 (0.41) | L3MBTL1TDP1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | MEDIHELPLINE CO., LTD (KR) | 2026-05-05 | — | — | US | disclosed |
| EP-4074325-B1 | COMPOSITION FOR PREVENTING, INHIBITING OR TREATING INFECTION OF CORONAVIRUS | AMOREPACIFIC CORP (KR) | 2024-07-31 | — | — | EP | disclosed |
| US-20240156888-A1 | SKIN EXTERNAL COMPOSITION AND METHOD FOR PREPARING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2024-05-16 | — | — | US | disclosed |
| US-20230127213-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER AND THE USE THEREOF | PARK, OK NAM (KR) | 2023-04-27 | — | — | US | disclosed |
| US-20230103514-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE SKIN REGENERATION AND THE TREATMENT OR ALLEVIATION OF SKIN WOUND AND THE USE THEREOF | MEDIHELPLINE CO., LTD (KR) | 2023-04-06 | — | — | US | disclosed |
| US-20230100173-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR TLSP INHIBITION AND THE TREATMENT OR ALLEVIATION OF SKIN INFLAMMATORY DISEASE AND THE USE THEREOF | MEDIHELPLINE CO., LTD (KR) | 2023-03-30 | — | — | US | disclosed |
| US-11583560-B2 | Immunomodulatory composition comprising lactobacillus-derived extracellular vesicles | AMOREPACIFIC CORPORATION (KR) | 2023-02-21 | — | — | US | disclosed |
| EP-4117700-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR TLSP INHIBITION AND THE TREATMENT OR ALLEVIATION OF SKIN INFLAMMATORY DISEASE AND THE USE THEREOF | Medihelpline Co., Ltd. (KR) | 2023-01-18 | — | — | EP | disclosed |
| EP-4117698-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE SKIN REGENERATION AND THE TREATMENT OR ALLEVIATION OF SKIN WOUND AND THE USE THEREOF | Medihelpline Co., Ltd. (KR) | 2023-01-18 | — | — | EP | disclosed |
| EP-4117699-A1 | A TOPICAL COMPOSITION COMPRISING AN EXTRACT OF COMBINED HERBS COMPRISING LONGANAE ARILLUS FOR THE TREATMENT OR ALLEVIATION OF SKIN ULCER AND THE USE THEREOF | Medihelpline Co., Ltd. (KR) | 2023-01-18 | — | — | EP | disclosed |
| EP-1793792-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA FOR PREVENTING AND TREATING BALDNESS DISORDERS AND SEBORRHEIC SKIN DISORDERS | Helixir Co., Ltd. (KR) | 2007-06-13 | — | — | EP | disclosed |
| US-20070122508-A1 | Composition comprising the extract of actinidia arguta and related species for the prevention and treatment of allergic disease and non-allergic inflammatory disease | HELIXIR CO., LTD. (KR) | 2007-05-31 | — | — | US | disclosed |
| WO-2007046636-A1 | HERBAL COMPOSITION FOR PREVENTING AND IMPROVING BALDNESS | KMSI CO., LTD (KR) | 2007-04-26 | — | — | WO | disclosed |
| WO-2007007989-A1 | LACTIC ACID BACTERIA CULTURE OF MUNG BEAN AND THE PREPARATION METHOD OF THE SAME, AND THE COSMETIC COMPOSITION COMPRISING THE SAME | DOOSAN CORPORATION (KR) | 2007-01-18 | — | — | WO | disclosed |
| WO-2006070978-A1 | COMPOSITION FOR PROMOTING PRODUCTION OF HYALURONIC ACID CONTAINING KAEMPFEROL AND QUERCETIN | AMOREPACIFIC CORPORATION (KR) | 2006-07-06 | — | — | WO | disclosed |
| WO-2006043788-A1 | COMPOSITION FOR PROTECTION AND IMPROVEMENT OF SKIN, OR REINFORCING SKIN BARRIER FUNCTION COMPRISING PHOSPHATIDYLSERINE | DOOSAN CORPORATION (KR) | 2006-04-27 | — | — | WO | disclosed |
| WO-2006016728-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA FOR PREVENTING AND TREATING BALDNESS DISORDERS AND SEBORRHEIC SKIN DISORDERS | HELIXIR CO., LTD. (KR) | 2006-02-16 | — | — | WO | disclosed |
| EP-1551433-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | Pangenomics Co., Ltd. (KR) | 2005-07-13 | — | — | EP | disclosed |
| WO-2004096171-A1 | SKIN WHITENING COSMETIC COMPOSITION COMPRISING THE EXTRACT OF MACHILUS THUNBERGII AND THE COMPOUNDS ISOLATED THEREFROM | YEUNGNAM EDUCATIONAL FOUNDATION (KR) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004017982-A1 | COMPOSITION COMPRISING THE EXTRACT OF ACTINIDIA ARGUTA AND RELATED SPECIES FOR THE PREVENTION AND TREATMENT OF ALLERGIC DISEASE AND NON-ALLERGIC INFLAMMATORY DISEASE | PANGENOMICS CO., LTD (KR) | 2004-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616730-B2 | Topical composition comprising an extract of combined herbs comprising longanae arillus for the treatment or alleviation of skin ulcer and the use thereof | CUTA, VEGFA, MMP8 | L3MBTL1 967/4885TDP1 1945/4885MEN1 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.